PHLDA2


Summary: This gene is located in a cluster of imprinted genes on chromosome 11p15.5, which is considered to be an important tumor suppressor gene region. Alterations in this region may be associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and lung, ovarian, and breast cancer. This gene has been shown to be imprinted, with preferential expression from the maternal allele in placenta and liver. [provided by RefSeq, Oct 2010].

NameOMIM IDEnsembl IDHGNC IDPHARMGKB IDMap Location
pleckstrin homology like domain family A member 2MIM:602131Ensembl:ENSG00000181649HGNC:HGNC:12385PA3705311p15.4

Gene Categories:

HORMONE ACTIVITY

GO terms in PHLDA2


Term TypeEvidence TypeGO Term IDGO Des.
BPIEAGO:0001890placenta development
BPTASGO:0006915apoptotic process
BPIEAGO:0009887animal organ morphogenesis
BPIEAGO:0010468regulation of gene expression
BPIEAGO:0030334regulation of cell migration
BPIEAGO:0060721regulation of spongiotrophoblast cell proliferation
BPIEAGO:0070873regulation of glycogen metabolic process
BPIEAGO:1903547regulation of growth hormone activity
CCIEAGO:0005737cytoplasm
CCIEAGO:0016020membrane

Gene expression in normal tissue: PHLDA2

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in PHLDA2


DatabasePathway IDPathway Des.

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD353PD03259012

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in PHLDA2

​​​​